Tuesday, April 18, 2023

16215: Diagnosing DE&I In White Healthcare Advertising Agencies.

 

PharmaLive hosted a Healthcare Agency Roundtable on DE&I—and the cultural confab showed how White healthcare advertising agencies are no more evolved than regular White advertising agencies—and may even be more culturally clueless.

 

The publication posed a straightforward question: “What is your organization doing to ensure that diversity, equity, and inclusion continues to be a prominent part of the conversation, having actionable impact and results?”

 

The Healthcare Human Heat Shields (whose portraits displayed a lack of diversity, equity, and inclusion) coughed up generic gobbledygook that could lead to serious side effects—or at least serious side eye.

 

The responses presented a wide range of labels (DE&I, EDI, DEI&B, DE+1, DEI, D&I), contrived commitment claims, diversionary drivel, heat shield schemes, and performative PR.

 

A few firms emphasized recognizing “an intersection between healthcare, environmental conditions, and racial disparities”—which means actual racial and ethnic hiring initiatives are being trumped by producing scammy campaigns that expose inequities in the healthcare system, embracing sustainability programs, and showing faux support for HBCUs.

 

Healthcare marketing has arguably held a lower subsegment position in the global marketing and advertising arena. The DE&I diagnosis, however, is not good—and may indicate advanced and progressive infirmities rooted in systemic racism. Ask your doctor if anti-racism is right for you.

No comments: